Synapse Open Synapse
Patents & IP

The enablement paradox and the danger of definitions (Wyeth v AstraZeneca)

IP Kat · · 7 min read

The Federal Circuit's decision in Wyeth v AstraZeneca (No. 2024-2325) applied the enablement test to a dose invention. The case is an interesting contrast to the other recent case to apply enablement to a method of treatment claim, Teva v Eli Lilly (IPKat).

Latest from IP Kat